Bilateral occlusive retinal vasculitis secondary to intravitreal faricimab injection: a case report and review of literature

This is the authors' abstract. We don't add key points for this paper.

BACKGROUND: This article describes a rare occurrence of bilateral retinal occlusive vasculitis secondary to intravitreal faricimab injection. CASE PRESENTATION: A 72-year-old female with age-related macular degeneration presented with bilateral retinal occlusive vasculitis following intravitreal faricimab injections. The patient was treated with 3 days of intravenous methylprednisolone followed by oral prednisolone taper and topical steroid therapy. Resolution of retinal occlusive vasculitis was observed 2 months post treatment. CONCLUSIONS: Retinal occlusive vasculitis is a rare complication of intravitreal anti-vascular endothelial growth factor (anti-VEGF), particularly with faricimab injections. We also present a review of literature regarding retinal occlusive vasculitis following intravitreal anti-VEGF injections and propose further information regarding its pathophysiology.